Advancing Evidence-Based Treatments
To expand therapy options, availability, and access, FDA is:
- Expanding availability and access to evidence-based treatments for substance use disorders
- Facilitating development of treatments for substance use disorders, with focus on stimulant use disorder
- Facilitating opportunities to incorporate stakeholder engagement into treatment development
United States Government Partners
- Department of Health & Human Services (HHS)
- Centers for Disease Control and Prevention (CDC)
- Centers for Medicare & Medicaid Services (CMS)
- Drug Enforcement Administration (DEA)
- National Institutes of Health (NIH)
- Substance Abuse and Mental Health Services Administration (SAMHSA)
- Indian Health Service (IHS)
- Veterans Affairs (VA)
FDA Activities
- Prescribe with Confidence Campaign
- Medications for Opioid Use Disorder (MOUD)
- FDA Takes Steps to Advance the Development of Novel Therapies for Stimulant Use Disorders
- FDA Takes Steps to Facilitate Innovation for Devices Intended to Treat Opioid Use Disorder
- FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder